Inflammation

SEATTLE — In this Healio Video Perspective from the Retina World Congress, David Almeida, MD, MBA, PhD, discusses combating gene therapy-associated uveitis.

Moderate to vigorous aerobic and resistance exercise may improve vascular function among cancer survivors, according to findings presented at American Association for Cancer Research Annual Meeting.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Riad Sherif, MD, CEO of Oculis, discusses the company’s two phase 3 clinical trials for the OCS-01 eye drop.

DENVER — A panel of four experts discussed different aspects of the ways brain health and climate change are linked at the American Academy of Neurology annual meeting.

Healio spoke with Joshua Baker, MD, about the importance of early treatment of rheumatoid arthritis, the unmet needs of patients with rheumatoid arthritis, common comorbid conditions associated with rheumatoid arthritis and more.

The FDA accepted an investigational new drug application for a trispecific fusion antibody for the treatment of diabetic macular edema, according to a press release from Eluminex Biosciences.

Black adolescents who face more racial discrimination may be more likely to have metabolic syndrome at age 31 years, according to findings published in JAMA Network Open.

Once-daily consumption of a supplement of lutein, zeaxanthin isomers, curcumin and vitamin D3 improved tear production and reduced ocular surface damage, inflammation and patient-reported symptoms in dry eye disease, according to research.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Steven M. Silverstein, MD, FACS, ABO, discusses IRIS Registry data related to Dextenza.

Ocugen has announced that dosing is complete in the second cohort of its phase 1/2 ArMaDa clinical trial to assess the safety of OCU410, a modifier gene therapy candidate for geographic atrophy.